Innoviva, Inc. Common Stock INVA
$21.19
+2.12%
at last close
Market Cap$1.50 billion
P/E Ratio—
Div Yield4.72%
Volume448.8K
52-Week Range
$16.52$25.14
Analyst Ratings
- Consensus
- Moderate Buy — 3 Buy · 0 Hold · 1 Sell (4 analysts)
- Avg. Price Target
- $34.75 (+64.0% upside)
Key Stats
- Today's Range
- $20.68 – $21.21
- 50-Day Range
- $20.20 – $24.17
- 52-Week Range
- $16.52 – $25.14
- Volume
- 449K shs
- Average Volume
- 758K shs
- Market Cap
- $1.50 billion
- P/E Ratio
- —
- Dividend Yield
- 4.72%
Dividend
- Dividend Yield
- 4.72%
- Annual Dividend
- $1.00
- Payout Ratio
- —
- Ex-Dividend Date
- 2015-09-08
Short Interest
- Short Interest
- 19.43%
- Days to Cover
- 20.53
About Innoviva, Inc. Common Stock
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Related Stocks
Compare head-to-head: INVA vs LLY·INVA vs JNJ·INVA vs ABBV·INVA vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.